1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019
- Contribution to journal › Article
-
Mark
First case of mpox with monkeypox virus clade Ib outside Africa in a returning traveller, Sweden, August 2024 : public health measures
- Contribution to journal › Article
- 2023
-
Mark
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation : I-MOVECOVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
- Contribution to journal › Article
-
Mark
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation : I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
- Contribution to journal › Article
- 2022
-
Mark
Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019 : a retrospective analysis
- Contribution to journal › Article
- 2021
-
Mark
Occupational risk of COVID-19 in the first versus second epidemic wave in Norway, 2020
- Contribution to journal › Scientific review
- 2017
-
Mark
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe : Results from the I-MOVE+ project
- Contribution to journal › Article
- 2016
-
Mark
Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals : Data for actions 2003-2010
- Contribution to journal › Article
